文献速递泌尿生殖MR

双参数MRI检测前列腺癌的诊断效能:系统评价与荟萃分析

Diagnostic Performance of Biparametric MRI for Detection of Prostate Cancer: A Systematic Review and Meta-Analysis.
PubMed 文献 · AJR Am J Roentgenol · 2018-06-12

该系统评价与荟萃分析纳入2000年1月至2017年7月发表的33项研究,评估双参数MRI检测前列腺癌的诊断效能,总敏感度为0.81、特异度为0.77,对临床相关前列腺癌AUC为0.85;头对头比较显示多参数MRI敏感度显著高于双参数MRI,但特异度无显著差异。

要点

  • 双参数MRI检测前列腺癌总敏感度0.81、特异度0.77,对临床相关前列腺癌AUC 0.85。
  • 头对头比较中多参数MRI敏感度0.85显著高于双参数MRI的0.80(p=0.01)。
  • 特异度多参数MRI 0.77与双参数MRI 0.80无显著差异(p=0.82)。

核心结论

  • 荟萃分析结果提示双参数MRI检测前列腺癌具有较高诊断准确度,并对临床相关前列腺癌保持较高检出率;但纳入研究间异质性高,应用该荟萃分析结果需谨慎。

研究设计与样本

  • 系统评价与荟萃分析,检索2000年1月至2017年7月发表的文献,共33项研究用于总体数据合并;病理参考标准为前列腺切除术或前列腺活检;采用诊断准确性研究质量评价工具评估研究质量。

诊断标准与关键数值

  • 双参数MRI检测前列腺癌总敏感度0.81(95%CI 0.76-0.85),总特异度0.77(95%CI 0.69-0.84)。
  • 双参数MRI检测临床相关前列腺癌AUC 0.85(95%CI 0.82-0.88)。
  • 头对头比较检测前列腺癌:多参数MRI敏感度0.85(95%CI 0.78-0.93)显著高于双参数MRI的0.80(95%CI 0.71-0.90)(p=0.01)。
  • 头对头比较检测前列腺癌:多参数MRI特异度0.77(95%CI 0.58-0.95)与双参数MRI的0.80(95%CI 0.64-0.96)无显著差异(p=0.82)。
  • 发表偏倚检验p=0.67,无发表偏倚证据。

局限性

  • 纳入研究间异质性高,应用该荟萃分析结果需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to perform a systematic review and meta-analysis to estimate the diagnostic performance of biparametric MRI (bpMRI) for detection of prostate cancer (PCa).

MATERIALS AND METHODS: Two independent reviewers performed a systematic review of the literature published from January 2000 to July 2017 by using predefined search terms. The standard of pathologic reference was established at prostatectomy or prostate biopsy. The numbers of true- and false-positive and true- and false-negative results were extracted. The Quality Assessment of Diagnostic Accuracy Studies tool was used to assess the quality of the selected studies. Statistical analysis included pooling of diagnostic accuracy, meta-regression, subgroup analysis, head-to-head comparison, and identification of publication bias.

RESULTS: Thirty-three studies were used for general data pooling. The overall sensitivity was 0.81 (95% CI, 0.76-0.85), and overall specificity was 0.77 (95% CI, 0.69-0.84). As for clinically relevant PCa, bpMRI maintained high diagnostic value (AUC, 0.85; 95% CI, 0.82-0.88). There was no evidence of publication bias (p = 0.67). From head-to-head comparison for detection of PCa, multiparametric MRI (mpMRI) had significantly higher pooled sensitivity (0.85; 95% CI, 0.78-0.93) than did bpMRI (0.80; 95% CI, 0.71-0.90) (p = 0.01). However, the pooled specificity values were not significantly different (mpMRI, 0.77 [95% CI, 0.58-0.95]; bpMRI, 0.80 [95% CI, 0.64-0.96]; p = 0.82).

CONCLUSION: The results of this meta-analysis suggest that bpMRI has high diagnostic accuracy in the detection of PCa and maintains a high detection rate for clinically relevant PCa. However, owing to high heterogeneity among the included studies, caution is needed in applying the results of the meta-analysis.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Niu XK, Chen XH, Chen ZF, et al. Diagnostic Performance of Biparametric MRI for Detection of Prostate Cancer: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2018. PMID: 29894216. doi:10.2214/AJR.17.18946

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。